Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.
This 2020 electron microscope image made available by the U.S. Centers for Disease Control and Prevention shows the spherical particles of the new coronavirus, colorized blue, from the first U.S. case of COVID-19. U.S. regulators on Monday, May 4 pulled back a decision that allowed scores of coronavirus blood tests to hit the market without first providing proof that they worked. The Food and Drug Administration said it took the action because some sellers have made false claims about the tests and their accuracy. (Hannah A. Bullock, Azaibi Tamin/CDC via AP, File)
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.